Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine

Por Wenger, Katharina J., Wagner, Marlies, You, Se-Jong, Franz, Kea, Harter, Patrick N., Burger, Michael C., Voss, Martin, Ronellenfitsch, Michael W., Fokas, Emmanouil, Steinbach, Joachim P., Bähr, Oliver
Publicado no Oncol Lett (2017)